Immunopathology of tuberculosis: Roles of macrophages and monocytes

Infection and Immunity

Volumn 64, Issue 3, 1996, Pages 683-690

  Fenton, Matthew J ^a   Vermeulen, Mary W ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; ANTIMICROBIAL ACTIVITY; CELL SURVIVAL; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; LUNG TUBERCULOSIS; MACROPHAGE FUNCTION; MOLECULAR INTERACTION; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; PRIMARY TUBERCULOSIS; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE; TUBERCULOSIS;

EID: 0030063866     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.3.683-690.1996     Document Type: Short Survey

References (97)

1. Barksdale, L., and K. S. Kim. 1977. Mycobacterium. Bacteriol. Rev. 41:217-372.
2. Barnes, P. F., D. Chatterjee, J. S. Abrams, S. Lu, E. Wang, M. Yamamura, P. J. Brennan, and R. L. Modlin. 1992. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J. Immunol. 149:541-547.
3. Barnes, P. F., V. Mehra, G. R. Hirschfield, S. J. Kong, C. Abou-Zeid, G. A. W. Rook, S. W. Hunter, P. J. Brennan, and R. W. Mudlin. 1989. Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis. J. Immunol. 143:2656-2662.
4. + T cells. Nature (London) 372:691-694.
5. 4a.Berman, J. S., R. L. Blumenthal, H. Kornfeld, J. A. Cook, W. W. Cruikshank, M. W. Vermeulen, and M. J. Fenton. Chemotactic activity of mycobacterial lipoarabinomannans for human blood T lymphocytes in vitro. Submitted for publication.
6. Bermudez, L., and J. Champsi. 1993. Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect. Immun. 61:3093-3097.
7. Besra, G. S., and D. Chatterjee. 1994. Lipids and carbohydrates of Mycobacterium tuberculosis, p. 285-306. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control ASM Press, Washington, D.C.
8. Blanchard, D. K., M. B. Michelini-Norris, C. A. Pearson, S. McMillen, and J. Y. Djeu. 1991. Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF. Infect Immun. 59:2396-2402.
9. Bloom, B. R., and C. J. L. Murray. 1992. Tuberculosis: commentary on a reemergent killer. Science 257:1055-1064.
10. Boom, W. H., K. A. Chervenak, M. A. Mincek, and J. J. Ellner. 1992. Role of the mononuclear phagocyte as an antigen-presenting cell for human γδ T cells activated by live Mycobacterium tuberculosis. Infect. Immun. 60:3480-3488.
11. Brennan, P. J. 1989. Structure of mycobacteria. recent developments in defining cell wall carbohydrates and proteins. Rev. Infect Dis. 11:5420-5430.
12. Brown, M. C., and S. M. Taffet. 1995. Lipoarabinomannans derived from different strains of Mycobacterium tuberculosis differentially stimulate the activation of NF-κB and KBF1 in murine macrophages. Infect. Immun 63:1960-1968.
13. Brunda, M. 1994. Interleukin 12. J. Leukocyte Biol. 55:280-288.
14. Chan, J., X. D. Fan, S. W. Hunter, P. J. Brennan, and B. R. Bloom. 1991. Lipoarabmomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect. Immun. 59:1755-1761
15. Chan, J., K. Tanaka, D. Carroll, J. Flynn, and B. Bloom. 1995 Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 63:736-740.
16. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122.
17. Chatterjee, D., A. D. Roberts, K. Lowell, P. J. Brennan, and I. M. Orme. 1992 Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor Infect. Immun. 60:1249-1253.
18. Constant, P., F. Davodeau, M. A. Peyrat, Y. Poquet, G. Puzo, M. Bonneville, and J. J. Fournie. 1994. Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science 264:267-270.
19. Daniel, T. M., J. H. Bates, and K. A. Downes. 1994. History of tuberculosis, p 13-24 In B R Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, D.C.
20. Dannenberg, A. J. 1982 Pathogenesis of pulmonary tuberculosis. Am. Rev. Respir. Dis. 125:25-29.
21. Dannenberg, A. M., Jr. 1993. Immunopathogenesis of pulmonary tuberculosis Hosp. Pract 28:51-58.
22. Denis, M. 1991. Killing of Mycobacterium tuberculosis within human monocytes. activation by cytokines and calcitriol. Clin Exp Immunol 84:200-206
23. Denis, M. 1991. Modulation of Mycobacterium avium growth in vivo by cytokines. involvement of tumour necrosis factor in resistance to atypical mycobacteria. Clin. Exp. Immunol. 83:466-471.
24. Denis, M. 1991 Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leukocyte Biol. 49:380-387.
25. Denis, M. 1994. Human monocytes/macrophages: NO or no NO. J. Leukocyte Biol. 55:682-684.
26. Denis, M., and E. Ghadirian. 1990. Granulocyte-macrophage colony-stimulating factor restricts growth of tubercle bacilli in human macrophages. Immunol. Lett 24:203-206.
27. Denis, M., and E. Ghadirian. 1991. Transforming growth factor beta (TGF-β1) plays a detrimental role in the progression of experimental Mycobacterium avium infection; in vivo and in vitro evidence Microb. Pathog. 11:367-372
28. Di Silvio, M., D. Geller, S. Gross, A. Nussler, P. Freeswick, R. Simmons, and T. Billiar. 1993. Inducible nitric oxide synthase activity in hepatocytes is dependent on the conduction of tetrahydrobiopterin synthesis. Adv. Exp. Med. Biol. 338:305-308.
29. Douvas, G. S., E. M. Berger, J. E. Repine, and A. J. Crowle. 1986. Natural mycobacteriostatic activity in human monocyte-derived adherent cells. Am. Rev. Respir. Dis. 134:44-48.
30. Flesch, I., and S. Kaufmann. 1991. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect. Immun. 59:3213-3218.
31. Flesch, I. E., and S. H. Kaufmann. 1993. Role of cytokines in tuberculosis. Immunobiology 189:316-339.
32. J. L. Flynn, M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. L. Lowenstein, R. D. Schreiber, T. W. Mak, B. R. Bloom. 1995. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572.
33. Flynn, J. L., M. M. Goldstein, K. J. Triebold, and B. R. Bloom. 1993. Major histocompatibility complex class I-restricted T cells are necessary for protection against M. tuberculosis in mice. Infect. Agents Dis. 2:259-262.
34. Fraser, R., J. Paré, P. Paré, R. Fraser, and G. Genereux. 1989. Diagnosis of diseases of the chest, 3rd ed., vol. II The W. B Saunders Co., Philadelphia.
35. Frehel, C., and N. Rastogi. 1987. Mycobacterium leprae surface components intervene in the early phagosome-lysosome fusion inhibition event. Infect Immun. 55:2916-2921.
36. Gazzineili, R., S. Hieny, T. Wynn, S. Wolf, and A. Sher. 1993 Interleukin 12 is required for the T lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T cell-deficient hosts. Proc Natl. Acad. Sci. USA 90:6115-6119
37. Gazzineili, R., I. Oswald, S. James, and A. Sher. 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol 148:1792-1796.
38. Haregewoin, A., B. Singh, R. S. Gupta, and R. W. Finberg. 1991 A mycobacterial heat-shock protein-responsive gamma delta T cell clone also responds to the homologous human heat-shock protein: a possible link between infection and autoimmunity. J. Infect. Dis. 163:156-160.
39. Hart, P., and M. Young. 1991. Ammonium chloride, an inhibitor of phagosome-lysosome fusion in macrophages, concurrently induces phagosome-endosome fusion, and opens a novel pathway: studies of a pathogenic mycobacterium and a nonpathogenic yeast. J. Exp. Med. 174:881-889.
40. Havlir, D. V., J. J. Ellner, K. A. Chervenak, and W. H. Boom. 1991. Selective expansion of human gamma delta T cells by monocytes infected with live Mycobacterium tuberculosis. J. Clin. Invest. 87:729-733.
41. Hopewell, P. C. 1994. Overview of clinical tuberculosis, p. 25-46. In B. R. Bloom (ed.), Tuberculosis: pathogenesis. protection, and control ASM Press, Washington, D.C.
42. Hunter, S., H. Gaylord, and P. Brennan. 1986 Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. J. Biol Chem. 261:12345-12351.
43. Ilangumaran, S., S. Ami, M. Poincelet, J. M. Theler, P. Brennan, N. ud-Din, and D. C. Hoessli. 1995. Integration of mycobacterial lipoarabinomannans into glycosylphosphatidylinositol-rich domains of lymphomonocytic cell plasma membranes J. Immunol. 155:1334-1342.
44. Kabelitz, D., A. Bender, T. Prospero, S. Wesselborg, O. Janssen, and K. Pechhold. 1991. The primary response of human gamma/delta+ T cells to Mycobacterium tuberculosis is restricted to V gamma 9-bearing cells. J. Exp Med 173:1331-1338.
45. Kindler, V., A. P. Sappino, G. E. Gran, P. E. Piguet, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740.
46. Kohzik, L., D. S. Bredt, C. J. Lowenstein, J. Drazen, B. Gaston, D. Sugarbaker, and J. S. Stamler. 1993. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization Am J. Cell Mol. Biol. 9:371-377.
47. Manz-Keinke, H., H. Plattner, and J. Schlepper-Schafer. 1992. Lung surfactant protein A (SP-A) enhances serum-independent phagocytosis of bacteria by alveolar macrophages. Eur. J. Cell Biol. 57:95-100.
48. Marodi, L., S. Schreiber, D. Anderson, R. MacDermott, H. Korchak, and R. J. Johnston. 1993. Enhancement of macrophage candidacidal activity by interferon-gamma: increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J Clin. Invest. 91:2596-2601
49. McDonough, K. A., Y. Kress, and B. R. Bloom. 1993. Pathogenesis of tuber-culosis: interaction of Mycobacterium tuberculosis with macrophages Infect Immun. 61:2763-2773
50. Nardell, E. 1993. Pathogenesis of tuberculosis, p. 103-123. In L. B. Reichman and E. Hirschfield (ed.). Lung biology in health and disease. Marcel Dekker, Inc., New York
51. Nathan, C., and J. Hibbs, Jr. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65-70.
52. Nathan, C., and Q.-W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918.
53. Nelson, B., P. Ralph, S. Green, and C. Nacy. 1991. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-β1. J. Immunol. 146:1849-1857.
54. Nussler, A., M. Di Silvio, T. Billiar, R. Hoffman, D. Geller, R. Selby, J. Madariaga, and R. Simmons. 1992. Stimulation of nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J. Exp. Med. 176:261-266.
55. O'Brien, L., J. Carmichael, D. Lowrie, and P. Andrew. 1994. Strains of Mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro. Infect. Immun. 62:5187-5190.
56. Ohmen, J., P. Barnes, C. Grisso, B. Bloom, and R. Modlin. 1994 Evidence for a superantigen in human tuberculosis. Immunity 1:35-43.
57. Orme, I. M. 1993. Immunity to mycobacteria. Curr Opin. Immunol. 5:497-502.
58. Orme, I. M., P. Andersen, and W. H. Boom. 1993. T cell response to Mycobacterium tuberculosis. J Infect. Dis. 167:1481-1497
59. Ozwald, I., R. Gazzinelli, A. Sher, and S. James. 1992. IL-10 synergizes with IL-4 and transforming growth factor beta to inhibit macrophage cytotoxic activity. J. Immunol. 148:3578-3582.
60. Pabst, M., J. Gross, J. Brozna, and M. Goren. 1988 Inhibition of macrophage priming by sulfatide from Mycobacterium tuberculosis. J. Immunol. 140:634-640.
61. Pancholi, P., A. Mirza, N. Bhardwaj, and R. M. Steinman. 1993. Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages. Science 260:984-986.
62. Peterson, P. K., G. Gekker, S. Hu, W. S. Sheng, W. R. Anderson, R. J. Ulevitch, P. S. Tobias, K. V. Gustafson, T. W. Molitor, and C. C. Chan. 1995. CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect. Immun 63:1598-1602.
63. Pugin, J., D. Heumann, A. Tomasz, V. Kravchenko, Y. Akamatsu, M. Nishijima, M. Glauser, P. Tobias, and R. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1:509-516.
64. Rastogi, N., M. Bachelet, and J. Carvalho de Sousa. 1992 Intracellular growth of Mycobacterium avium in human macrophages is linked to the increased synthesis of prostaglandin E2 and inhibition of the phagosome-lysosome fusions. FEMS Microbiol. Immunol 4:273-279.
65. Reiling, N., A. Ulmer, M. Duchrow, M. Ernst, H. Flad, and S. Hauschildt. 1994 Nitric oxide synthase, mRNA expression of different isoforms in human monocytes/macrophages. Eur. J. Immunol. 24:1941-1944.
66. Riley, R. L., C. L. Mills, W. Nyka, N. Weinstock, P. B. Storey, L. K. Sultan, M. C. Riley, and W. F. Wells. 1959. Aerial dissemination of pulmonary tuberculosis: a two year study of contagion in a tuberculosis ward. Am J Hyg. 70:185-196.
67. Roach, T. I., C. H. Barton, D. Chatterjee, and J. M. Blackwell. 1993. Macrophage activation lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha. J. Immunol. 150:1886-1896.
68. Roach, T. I., D. Chatterjee, and J. M. Blackwell. 1994. Induction of early-response genes KC and JE by mycobacterial lipoarabinomannans, regulation of KC expression in murine macrophages by Lsh/Ity/Bcg (candidate Nramp). Infect. Immun 62:1176-1184.
69. Schlesinger, L. S. 1993. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors J. Immunol 150:2920-2930.
70. Schlesinger, L. S., C. G. Bellinger-Kawahara, N. R. Payne, and M. A. Horwitz. 1990. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J. Immunol. 144:2771-2780.
71. Schlesinger, L. S., and M. A. Horowitz. 1991. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-γ activation inhibits complement receptor function and phagocytosis of this bacterium J Immunol. 147:1983-1994.
72. Schlesinger, L. S., S. R. Hull, and T. M. Kaufman. 1994. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages J. Immunol 152:4070-4079.
73. Schmitt, E., G. Meuret, and L. Stix. 1977. Monocyte recruitment in tuber-culosis and sarcoidosis Br. J. Haematol. 35:11-17
74. Schoendon, G., J. Troppmair, A. Fontana, C. Huber, H.-C. Curtis, and A. Neiderwieser. 1987. Biosynthesis and metabolism of pterins in peripheral blood mononuclear cells and leukemia lines of man and mouse. Eur. J. Biochem. 166:303-310.
75. Schreiber, S., S. Perkins, S. Teitelbaum, J. Chappel, P. Stahl, and J. Slum. 1993. Regulation of mouse bone marrow macrophage mannose receptor expression and activation by prostaglandin E and IFN-gamma J. Immunol. 151:4973-4981.
76. Shiratsuchi, H., J. Johnson, and J. Ellner. 1991. Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes. J. Immunol. 146:3165-3170.
77. Sieling, P. A., D. Chatterjee, S. A. Porcelli, T. I. Progozy, R. J. Mazzaccaro, T. Soriano, B. R. Bloom, M. B. Brenner, M. Kronenberg, P. J. Brennan, and R. L. Modlin. 1995 CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269:227-230.
78. Soler, P., and J. F. Bernaudin. 1993. Physiology of granulomas. Rev. Pneumol. Clinique 49:257-261.
79. Spencer, H. 1985. Pathology of the lung, 4th ed., vol. 1. Pergamon Press, Oxford.
80. Stander, J., D. Singel, and J. Loscalzo. 1992. Biochemistry of nitric oxide and its redox-activated forms. Science 258:1898-1902.
81. Steck, P. A., B. A. Schwartz, M. S. Rosendahl, and G. R. Gray. 1978. Mycolic acids: a reinvestigation. J. Biol Chem. 253:5625-5709.
82. Stein, M., S. Keshav, N. Harris, and S. Gordon. 1992 Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176:287-292.
83. Sturgill-Koszycki, S., P. H. Schlesinger, P. Chakraborty, P. L. Haddix, H. L. Collins, A. K. Fok, R. D. Allen, S. L. Gluck, J. Heuser, and D. G. Russell. 1994. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263:678-681
84. Taylor, M. 1993. Recognition of complex carbohydrates by the macrophage mannose receptor. Biochem. Soc. Trans. 21:468-473.
85. Toossi, Z., P. Gogate, H. Shiratsuchi, T. Young, and J. Ellner. 1995. Enhanced production of TGF-β by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculous granulomatous lung lesions. J. Immunol. 154:465-473.
86. Venisse, A., J.-M. Berjeaud, P. Chaurand, M. Gilleron, and G. Puzo. 1993. Structural features of lipoarabinomannan from Mycobacterium bovis BCG. J Biol. Chem. 268:12401-12411.
87. 85a.Vermeulen, M. W., and M. J. Fenton. Immunopathology of tuberculosis. In R. L. Kradin (ed.), Immunopathology of inflammatory lung disease, in press Butterworth-Heinemann, Newton, Mass.
88. Warwick-Davies, J., J. Dhillon, L. O'Brien, P. W. Andrew, and D. B. Lowrie. 1994. Apparent killing of Mycobacterium tuberculosis by cytokine-activated human monocytes can be an artefact of a cytotoxic effect on the monocytes. Clin. Exp. Immunol. 96:214-217.
89. Werner, E., G. Verner-Felmayer, D. Fuchs, A. Hausen, G. Reibnegger, and H. Wachter. 1989. Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon gamma. Biochem. J 262:861-866.
90. Xu, S., A. Cooper, S. Sturgill-Koszycki, T. van Heyningen, D. Chatterjee, I. Orme, P. Allen, and D. Russell. 1994. Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. J Immunol. 153:2568-2578
91. Youmans, G., and A. Youmans. 1964. An active pulmonary granulomatous response in mice produced by mycobacterial cells and its relation to increased resistance and increased susceptibility to experimental tuberculosis infection. J. Infect. Dis. 114:135-141.
92. Youmans, G. P. 1979. Tuberculosis The W B. Saunders Co , Philadelphia.
93. Zhang, M., M. K. Gately, E. Wang, J. Gong, S. F. Wolf, S. Lu, R. L. Modlin, and P. F. Barnes. 1994. Interteukin 12 at the site of disease in tuberculosis. J. Clin. Invest. 93:1733-1739
94. Zhang, M., J. Gong, D. Iyer, B. Jones, R. Modlin, and P. Barnes. 1994. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection J Clin. Invest. 94:2435-2442.
95. Zhang, Y., M. Broser, H. Cohen, M. Bodkin, K. Law, J. Reibman, and W. Rom. 1995. Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J. Clin. Invest. 95:586-592.
96. Zhang, Y., M. Doerfler, T. C. Lee, B. Guillemin, and W. N. Rom. 1993. Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components. J. Clin. Invest. 91:2076-2083.
97. Zhu, L., C. Gunn, and J. Beckman. 1992. Bactericidal activity of peroxynitrite. Arch. Biochem Biophys. 298:452-457